D70.1

ICD-10Billable

Agranulocytosis secondary to cancer chemotherapy

Official ICD-10-CM descriptor (FY2026)

Agranulocytosis secondary to cancer chemotherapy

D70.1 is valid for submission on a claim — CMS flags it as a billable, specific code.

Use additional code

Report an additional code to identify the associated condition.

code for adverse effect, if applicable, to identify drug (T45.1X5)

Code also

Two codes may be needed; sequencing depends on the reason for the encounter.

underlying neoplasm

Related codes in D70

Where this code sits

Chapter: 3. Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Block: Other disorders of blood and blood-forming organs (D70-D77)
Parent code: D70

Krasyn AI Coder

Get code suggestions automatically as you type notes. Free for 50 analyses.

Install for Chrome — free

Source

ICD-10-CM FY2026. Centers for Medicare & Medicaid Services (CMS) / National Center for Health Statistics (NCHS), “2026 ICD-10-CM Code Descriptions in Tabular Order” (icd10cm_order_2026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.